ruthenium has been researched along with 4-(n-maleimido)benzyltrimethylammonium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajji, L; Romerosa, A; Saraiba-Bello, C; Scalambra, F; Segovia-Torrente, G | 1 |
1 other study(ies) available for ruthenium and 4-(n-maleimido)benzyltrimethylammonium
| Article | Year |
|---|---|
Ru complexes containing Cp, mPTA and natural purine bases (mPTA = methyl-N-1,3,5-triaza-7-phosphaadamantane): Evaluation of their antiproliferative activity, solubility and redox properties.
Topics: Antineoplastic Agents; Cell Proliferation; Coordination Complexes; Female; Humans; Ovarian Neoplasms; Oxidation-Reduction; Purines; Quaternary Ammonium Compounds; Ruthenium; Solubility | 2021 |